TORONTO, March 13, 2012 /PRNewswire/ - Patheon Inc. (TSX: PTI), a leading
provider of contract development and manufacturing services to the
global pharmaceutical industry, announced today that it will host a
conference call and Web cast allowing interested persons to listen to
its Annual and Special Meeting of Shareholders (the "Annual Meeting")
to be held on Thursday, March 22, 2012, beginning at 10:30 a.m. (EDT).
The Annual Meeting will be held at The Fairmont Royal York Hotel in
Toronto, Ontario, Canada. Patheon's 2011 Annual Report and its Proxy
Statement and Information Circular for the Annual Meeting can be viewed
Interested parties are invited to listen to the annual meeting, via
telephone, toll free at (888) 231-8191 (U.S., including Puerto Rico)
and (647) 427-7450 (Canada and International). To view the slides
accompanying the annual meeting presentation click here. The link to the Web cast will also be posted on the investor
relations section of Patheon's Web site prior to the call. Persons
wishing to listen to the Annual Meeting are encouraged to dial in five
to fifteen minutes in advance to avoid delays. A live audio will also
be available via the web at http://ir.patheon.com/events.cfm. (Please note that either Windows Media Player or RealPlayer are
A telephone replay of the Annual Meeting will be available between March
22, 2012 and April 5, 2012 by dialing 1-855-859-2056(toll free) or 1-403-451-9481, and by entering identification number
59993373, followed by the number key. The Web cast will also be
archived at http://ir.patheon.com/events.cfm.
Patheon Inc. (TSX: PTI) is a leading global provider of contract
development and manufacturing services to the global pharmaceutical
industry. The company provides the highest quality products and
services to approximately 300 of the world's leading pharmaceutical and
biotechnology companies. Its services range from preclinical
development through commercial manufacturing of a full array of dosage
forms including parenteral, soft gel, solid and liquid forms.
The company's comprehensive range of fully integrated Pharmaceutical
Development Services includes pre-formulation, formulation, analytical
development, clinical manufacturing, scale-up and commercialization.
The company's integrated development and manufacturing network of 10
manufacturing facilities, nine development centers and one clinical
trial material packaging facility across North America and Europe,
enables customer products to be launched with confidence anywhere in
SOURCE Patheon Inc.